81 research outputs found
Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma
Clustered miRNAs can affect functioning of downstream pathways due to possible coordinated function. We
observed 78-88% of the miR-379/miR-656 cluster (C14MC) miRNAs were downregulated in three sub-types
of diffuse gliomas, which was also corroborated with analysis from The Cancer Genome Atlas (TCGA)
datasets. The miRNA expression levels decreased with increasing tumor grade, indicating this
downregulation as an early event in gliomagenesis. Higher expression of the C14MC miRNAs significantly
improved glioblastioma prognosis (Pearson’s r=0.62; p<3.08e-22). ENCODE meta-data analysis, followed by
reporter assays validated existence of two novel internal regulators within C14MC. CRISPR activation of the
most efficient internal regulator specifically induced members of the downstream miRNA sub-cluster and
apoptosis in glioblastoma cells. Luciferase assays validated novel targets for miR-134 and miR-485-5p, two
miRNAs from C14MC with the most number of target genes relevant for glioma. Overexpression of miR-134
and miR-485-5p in human glioblastoma cells suppressed invasion and proliferation, respectively.
Furthermore, apoptosis was induced by both miRs, individually and in combination. The results emphasize
the tumor suppressive role of C14MC in diffuse gliomas, and identifies two specific miRNAs with potential
therapeutic value and towards better disease management and therapy
Physiological Notch Signaling Maintains Bone Homeostasis via RBPjk and Hey Upstream of NFATc1
Notch signaling between neighboring cells controls many cell fate decisions in metazoans both during embryogenesis and in postnatal life. Previously, we uncovered a critical role for physiological Notch signaling in suppressing osteoblast differentiation in vivo. However, the contribution of individual Notch receptors and the downstream signaling mechanism have not been elucidated. Here we report that removal of Notch2, but not Notch1, from the embryonic limb mesenchyme markedly increased trabecular bone mass in adolescent mice. Deletion of the transcription factor RBPjk, a mediator of all canonical Notch signaling, in the mesenchymal progenitors but not the more mature osteoblast-lineage cells, caused a dramatic high-bone-mass phenotype characterized by increased osteoblast numbers, diminished bone marrow mesenchymal progenitor pool, and rapid age-dependent bone loss. Moreover, mice deficient in Hey1 and HeyL, two target genes of Notch-RBPjk signaling, exhibited high bone mass. Interestingly, Hey1 bound to and suppressed the NFATc1 promoter, and RBPjk deletion increased NFATc1 expression in bone. Finally, pharmacological inhibition of NFAT alleviated the high-bone-mass phenotype caused by RBPjk deletion. Thus, Notch-RBPjk signaling functions in part through Hey1-mediated inhibition of NFATc1 to suppress osteoblastogenesis, contributing to bone homeostasis in vivo
Synthesis of a Dual Functional Anti-MDR Tumor Agent PH II-7 with Elucidations of Anti-Tumor Effects and Mechanisms
Multidrug resistance mediated by P-glycoprotein in cancer cells has been a major issue that cripples the efficacy of chemotherapy agents. Aimed for improved efficacy against resistant cancer cells, we designed and synthesized 25 oxindole derivatives based on indirubin by structure-activity relationship analysis. The most potent one was named PH II-7, which was effective against 18 cancer cell lines and 5 resistant cell lines in MTT assay. It also significantly inhibited the resistant xenograft tumor growth in mouse model. In cell cycle assay and apoptosis assay conducted with flow cytometry, PH II-7 induced S phase cell cycle arrest and apoptosis even in resistant cells. Consistently revealed by real-time PCR, it modulates the expression of genes related to the cell cycle and apoptosis in these cells, which may contributes to its efficacy against them. By side-chain modification and FITC-labeling of PH II-7, we were able to show with confocal microscopy that not only it was not pumped by P-glycoprotein, it also attenuated the efflux of Adriamycin by P-glycoprotein in MDR tumor cells. Real-time PCR and western blot analysis showed that PH II-7 down-regulated MDR1 gene via protein kinase C alpha (PKCA) pathway, with c-FOS and c-JUN as possible mediators. Taken together, PH II-7 is a dual-functional compound that features both the cytotoxicity against cancer cells and the inhibitory effect on P-gp mediated drug efflux
Entropy analysis on convective film flow of power-law fluid with nanoparticles along an inclined plate
Entropy generation in a two-dimensional steady laminar thin film convection flow of a non-Newtonian nanofluid (Ostwald-de-Waele-type power-law fluid with embedded nanoparticles) along an inclined plate is examined theoretically. A revised Buongiorno model is adopted for nanoscale effects, which includes the effects of the Brownian motion and thermophoresis. The nanofluid particle fraction on the boundary is passively rather than actively controlled. A convective boundary condition is employed. The local nonsimilarity method is used to solve the dimensionless nonlinear system of governing equations. Validation with earlier published results is included. A decrease in entropy generation is induced due to fluid friction associated with an increasing value of the rheological power-law index. The Brownian motion of nanoparticles enhances thermal convection via the enhanced transport of heat in microconvection surrounding individual nanoparticles. A higher convective parameter implies more intense convective heating of the plate, which increases the temperature gradient. An increase in the thermophoresis parameter decreases the nanoparticle volume fraction near the wall and increases it further from the wall. Entropy generation is also reduced with enhancement of the thermophoresis effect throughout the boundary layer
Sex differences in the genome-wide DNA methylation pattern and impact on gene expression, microRNA levels and insulin secretion in human pancreatic islets
- …